ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.745
-0.025 (-1.41%)
May 12, 2026, 11:23 AM EDT - Market open
ProKidney Market Cap
ProKidney has a market cap or net worth of $526.92 million as of May 12, 2026. Its market cap has increased by 81.82% in one year.
Market Cap
526.92M
Enterprise Value
279.06M
1-Year Change
81.82%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $526.92M, an increase of 103.60%. That is a compound annual growth rate of 15.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 561.60M | -16.66% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
| Jun 30, 2021 | 258.80M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 583.35M |
| Avalo Therapeutics | 576.23M |
| Prime Medicine | 568.63M |
| Kyverna Therapeutics | 565.96M |
| Prothena Corporation | 561.75M |
| Tectonic Therapeutic | 546.61M |
| REGENXBIO | 544.56M |
| Climb Bio | 543.13M |